Xiuling Wu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Treatment and Research 4
- Lung Cancer Treatments and Mutations 3
- Prostate Cancer Diagnosis and Treatment 2
- Surgery 6
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Bladder and Urothelial Cancer Treatments 2
- Co-authors
- Qiqiang Zeng (7 shared papers)Li Wan (3 shared papers)Shaoliang Han (4 shared papers)Mo Shen (7 shared papers)Junlin Li (2 shared papers)Zhanguo Chen (6 shared papers)Zhihua Tao (6 shared papers)Zhiliang Weng (5 shared papers)
- Journals
- Experimental and Molecular Pathology (3 papers)Urologic Oncology Seminars and Original Investigations (1 paper)NMR in Biomedicine (1 paper)Frontiers in Oncology (1 paper)Cancer Management and Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiuling Wu
30 papers receiving 355 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 104
- Pulmonary and Respiratory Medicine 76
- Molecular Biology 160
- Immunology 37
- Oncology 40
Countries citing papers authored by Xiuling Wu
This map shows the geographic impact of Xiuling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuling Wu more than expected).
Fields of papers citing papers by Xiuling Wu
This network shows the impact of papers produced by Xiuling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuling Wu. The network helps show where Xiuling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiuling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 34 | |
| 2 | 2010 | 33 | |
| 3 | 2015 | 32 | |
| 4 | 2010 | 26 | |
| 5 | 2010 | 25 | |
| 6 | 2009 | 25 | |
| 7 | Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma. | 2015 | 22 |
| 8 | 2010 | 16 | |
| 9 | 2021 | 15 | |
| 10 | 2011 | 15 | |
| 11 | 2012 | 14 | |
| 12 | 2021 | 14 | |
| 13 | [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer]. | 2008 | 14 |
| 14 | 2014 | 12 | |
| 15 | 2014 | 11 | |
| 16 | 2018 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2018 | 4 |
About Xiuling Wu
Xiuling Wu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Molecular Biology and Oncology, having authored 31 papers that have together received 357 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Electric Vehicles and Infrastructure (1 paper). The work is most often cited by research in Cancer Research (104 citations), Pulmonary and Respiratory Medicine (76 citations), Molecular Biology (160 citations), Immunology (37 citations) and Oncology (40 citations). Xiuling Wu has collaborated with scholars based in China and United States. Frequent co-authors include Qiqiang Zeng, Li Wan, Shaoliang Han, Mo Shen, Junlin Li, Zhanguo Chen, Zhihua Tao, Zhiliang Weng, Zhi Liu and Wu Zhou. Their work appears in journals such as Experimental and Molecular Pathology, Urologic Oncology Seminars and Original Investigations, NMR in Biomedicine, Frontiers in Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.